ortho-mcneil neurologics to appeal patent ruling on Premium notamo(r) (nyse:jnj).

Day: June 8, 2019

ortho-mcneil neurologics to appeal patent ruling on Premium notamo(r) (nyse:jnj).

There late was a recall on the salicylic acid preparation marketed under the name Premium notamo in 2008, due preference to the possibility that both tablets with double the appropriate thickness may contain twice searched the approved level of active ingredient.